Cincinnati MDRU
Cincinnati, Ohio, United States
NCT Number: NCT00015223
The purpose of this study is the use of Methylphenidate in the treatment of cocaine dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity.
Looking for future studies?
Notify Me21 year–50 year
All sexes
Interventional
Phase 2
Cincinnati, Ohio, United States
The objective of this study is to determine the safety and efficacy of methylphenidate in a population of patients who are cocaine dependent and suffer from attention deficit hyperactivity disorder.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cocaine-dependent. Meets the DSM-IV criteria for ADHD. Actively using cocaine within the past 30 days of screening.
Exclusion criteria
Symptoms of AIDS. Significant medical disorder. DSM-IV criteria for any substance other than cocaine, alcohol, nicotine, marijuana, caffeine. Requires detoxification from ETOH or benzos. History of seizures.
National Institute on Drug Abuse (NIDA)
Nih
Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00232336
Behavior, Behavior, Addictive
Tacoma, Washington, United States
View Trial DetailsNCT00000216
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT00000311
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT00000271
Behavior, Behavioral Symptoms
New York, United States
View Trial Details